Metropolitan Life Insurance Company (MetLife)’s Annexon ANNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,603
Closed -$25.8K 144
2024
Q1
$25.8K Buy
+3,603
New +$18.7K ﹤0.01% 1737
2023
Q3
Sell
-2,525
Closed -$8.89K 2403
2023
Q2
$8.89K Buy
+2,525
New +$11K ﹤0.01% 2355
2022
Q1
Sell
-8,725
Closed -$100K 2269
2021
Q4
$100K Hold
8,725
﹤0.01% 2480
2021
Q3
$162K Hold
8,725
﹤0.01% 2239
2021
Q2
$196K Buy
8,725
+924
+12% +$20.5K ﹤0.01% 2155
2021
Q1
$217K Buy
7,801
+3,109
+66% +$85.5K ﹤0.01% 1963
2020
Q4
$117K Hold
4,692
﹤0.01% 2272
2020
Q3
$142K Buy
+4,692
New +$110K ﹤0.01% 2005

Other funds holding ANNX

Metropolitan Life Insurance Company (MetLife)'s ANNX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Annexon (ANNX) in Q2 2024, closing a stake of 3,603 shares — an estimated $25.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ANNX in Q3 2020 and held it in 8 quarters. The position peaked at $217K in Q1 2021. 140 funds tracked by Wall St. Rank hold ANNX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Annexon position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,603 Annexon shares in Q2 2024, an estimated $25.8K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Annexon in Q3 2020 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Annexon position peaked at $217K in Q1 2021.
  • 140 funds tracked by Wall St. Rank held Annexon as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.